Martin Kelleher, Corporate Partner and Head of Life Sciences, represented Vysera Biomedical Limited in a significant transaction with Merit Medical Systems Inc. (NASDAQ:MMSI). The transaction involved Merit entering into a licence, development and supply agreement relating to Vysera's proprietary valve technology and biomaterial technology as well as taking an equity stake in Vysera.
For more information, please contact Martin Kelleher, Corporate Partner and Head of Life Sciences at mkelleher@mhc.ie or + 353 1 614 5000.
t +353 1 614 5000
f +353 1 614 5001
e mail@mhc.ie
South Bank House,
Barrow Street,
Dublin 4 Ireland.
t +44 20 3178 3368
f +44 20 3178 3367
e mail@mhcldn.com
60 Lombard Street,
London EC3V 9EA,
UK.
t +1 212 786 7376
f +1 212 786 7316
e mail@mhcny.com
330 Madison Avenue,6th Floor,
New York NY
10017 ,
USA.